Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Depreciation & Amortization (CF) (2020 - 2025)

Rapid Micro Biosystems' Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $804000.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) fell 6.4% year-over-year to $804000.0; the TTM value through Sep 2025 reached $3.3 million, up 1.34%, while the annual FY2024 figure was $3.4 million, 8.28% up from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $804000.0 at Rapid Micro Biosystems, down from $811000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $869000.0 in Q4 2024 and bottomed at $300000.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $781000.0 (2023), against an average of $694684.2.
  • The largest annual shift saw Depreciation & Amortization (CF) decreased 25.0% in 2021 before it skyrocketed 127.67% in 2022.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $450000.0 in 2021, then skyrocketed by 91.11% to $860000.0 in 2022, then fell by 7.67% to $794000.0 in 2023, then grew by 9.45% to $869000.0 in 2024, then fell by 7.48% to $804000.0 in 2025.
  • Per Business Quant, the three most recent readings for RPID's Depreciation & Amortization (CF) are $804000.0 (Q3 2025), $811000.0 (Q2 2025), and $847000.0 (Q1 2025).